This time, the United States approved one dose of Johnson's ticker

International Desk: This time the United States has approved the Johnson & Johnson ticker. This is the third corona vaccine approved in the United States. Earlier, Pfizer-Biotech and Modern vaccines were approved in the country.

The British media reported on the BBC. According to the BBC, the Belgian company Johnson has produced a single dose of the vaccine. Johnson & Johnson will be vaccinated in the United States early next week. The company says it will give 100 million vaccines in the United States by June.

Johnson's one-dose vaccine is cheaper than others and easier to transport. It does not require a cold chain or freezing temperature, it can be stored at normal refrigerator temperature for months.

In trials in the United States, South Africa, and Brazil, the vaccine has been shown to be effective in more than 75 percent of critically ill patients. And overall, it has proven to be 6 percent effective. U.S. President Joe Biden is excited about the news of Johnson's approval of the vaccine.

"This is good news and a commendable achievement for everyone in the United States," he said. But it must also be remembered that "the fight is not over yet." "We will celebrate this news today," Biden said in a statement.

Even then, I would urge everyone to wash their hands, adhere to social distances, and wear masks. I have said many times that the new type of corona could worsen the situation again and the current development picture may change again. '